Full text is available at the source.
Mechanisms by which the orexigen NPY regulates anorexigenic α-MSH and TRH
How the hunger signal NPY controls appetite-suppressing α-MSH and TRH
AI simplified
Abstract
NPY inhibited the processing of proopiomelanocortin (POMC), which is the precursor for α-melanocyte-stimulating hormone (α-MSH).
- Neuropeptide Y (NPY) suppresses α-MSH and thyrotropin-releasing hormone (TRH), contributing to positive energy balance.
- NPY decreases the activity of prohormone convertase-2 (PC2), which is necessary for α-MSH generation from POMC.
- The reduction in PC2 by NPY is mediated by early growth response protein-1 (Egr-1) and NPY-Y1 receptors.
- Intra-PVN administration of NPY lowers PC2 levels, indicating a potential decrease in TRH processing.
- NPY also reduces the α-MSH-induced increase in TRH production by decreasing α-MSH levels and inhibiting CREB phosphorylation.
AI simplified